Trademark Overview
On Wednesday, March 16, 2022, a trademark application was filed for TRANSCARDIA with the United States Patent and Trademark Office. The USPTO has given the TRANSCARDIA trademark a serial number of 97314595. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, March 18, 2024. This trademark is owned by Transcardia, LLC. The TRANSCARDIA trademark is filed in the Computer & Software Services & Scientific Services, Medical & Beauty Services & Agricultural Services, Personal, and Legal & Social Services categories with the following description:
Regulatory compliance consulting, namely consulting in the field of regulatory affairs including for pharmaceuticals, therapies, and medical devices in the preclinical, clinical and commercial stage
Providing medical information, consultancy, and advisory services to medical professionals in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals and medical devices; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; Medical evaluation services for patients of gene modification, organ transplants, xenotransplantation, regenerative medicine, and advanced therapies for purposes of guiding treatment and assessing effectiveness
Scientific and technological consulting services, namely, providing medical and scientific research information in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical devices; Scientific and technological research, namely, providing information in the field of pharmaceutical preclinical and clinical research and development; quality management services, namely quality evaluation and analysis, quality assurance, and quality control in the field of gene modification technology, organ transplants, xenotransplantation, regenerative medicine, advanced therapies, advanced therapeutic medicinal products, biologics, pharmaceuticals, and medical device manufacturing; scientific research and development for medical purposes; compiling data for research purposes in the field of medical science and medical consultancy; design and testing for new...